All News

In addition to the ongoing COVID-19 pandemic, significant public health concerns include opioid overdoses, maternal mortality disparities, and climate change.

FDA Commissioner Robert Califf said that misinformation is the most common cause of death in the United States.

Healthcare practitioner finds that institutions need to acknowledge advantaged and disadvantaged groups of patients as motivation to overcome systemic barriers.

Pharmacists should get out from behind the glass from time to time and work with chronic kidney disease patients to better understand their medications and lifestyle decisions, said an analyst who spoke at ASN Kidney Week in Orlando, Florida.

Researchers outline new findings about the connection between hyperkalemia and renin-angiotensin-aldosterone system inhibitors during a session at ASN Kidney Week.

Applying the principles of precision medicine to peritoneal dialysis could improve the flexibility and personalization of care for dialysis patients.

When diabetes is uncontrolled, higher percentages of hemoglobin become glycated, which causes elevated HbA1c and glucose levels to rise within the body.

Infection with RSV can take a variety of forms, ranging from a mild upper respiratory tract infection to severe, life-threatening acute respiratory failure.

WHO has released a global plan for hepatitis B elimination by 2030, including goals to increase pediatric and maternal immunization and to improve screening and treatment.

Systemically administered hormonal therapy may be associated with a greater risk of depression before and during menopause.

Elranatamab is a B-cell maturation antigen (BCMA)-CD3-targeted bispecific antibody.

Promising data suggest triplet regimens may more effectively treat patients with unresected and metastatic intrahepatic cholangiocarcinoma.

Education, awareness, and more training may help more pharmacists and kidney patients consider home dialysis as an effective treatment option, said an expert on November 4 at ASN Kidney Week in Orlando, Florida.

Psoriasis and end-stage renal disease are believed to share multiple pathogenic pathways, including various cytokines, reactive oxygen species, and psoriasis medications.

Among heart failure patients, those who were at risk of social isolation had a worse attitude about advance care planning.

Researcher suggests that medications for high blood pressure may be useful in treating patients with slow-onset immunoglobulin A nephropathy, a topic he will present on this weekend at ASN Kidney Week in Orlando, Florida.

Daniel Weiner, MD, MS, associate professor at Tufts University, discusses effective treatment approaches for diabetic kidney disease at ASN Kidney Week.

It may be worth considering the pathophysiology and vascular complications of chemotherapy, especially among patients who are already hypertensive.

Pharmacists are the premier medication experts within health care, who understand more about medication interactions than most physicians and have the unique ability to prevent complications, improve adherence, and save lives.

Some of the most frequently noted biotin interferences are with immunoassays for thyroid markers, high-sensitivity cardiac troponin, and N-terminal pro-brain natriuretic peptide.

In the inpatient acute care setting, oncology pharmacists maximize return on investments of oncology products, produce optimal outcomes, and ensure that quality of care is consistent and safe.

Teprotumumab is the first fully human IgG1 monoclonal antibody approved by the FDA for the treatment of thyroid eye disease at its source not just reducing the symptoms.

As pharmacists, it’s important to understand and embrace the science and the tools that COVID-19 has brought.

Among nicotine users, there was an approximately 4 beat per minute jump in heart rate after vaping or smoking.

Investigational broadly neutralizing antibody shows promise as potential as a first-in-class treatment option for HIV.

Researchers observed disparities in health outcomes between Black individuals and White individuals due to stroke, diabetes, and coronary heart disease.

Eisai plans to file for traditional approval in the United States by March 31, 2023.

Pharmacy leaders and academics have been begging the profession to evolve for decades. It took a pandemic to make it happen.

The results showed that these participants were more than 27 times as likely to develop VTE, more than 21.5 times as likely to be diagnosed with heart failure, and 17.5 times as likely to have a stroke.

Pre-planned safety reviews performed for the duration of the study found that the investigational vaccine is well-tolerated with no safety concerns for both the vaccinated individuals and their newborns.